Recipharm AB: Interim Report January – March 2014

Regulatory News:

Recipharm AB (STO:RECI):

· Net sales amounted to SEK 578 million (517) an increase of 11,7 % (9,4% in constant FX-rates)

Help employers find you! Check out all the jobs and post your resume.